Results 131 to 140 of about 303,943 (292)

TRANSLATIONAL CKD RESEARCH [PDF]

open access: yesNephrology Dialysis Transplantation, 2014
Freedman, B.S.   +50 more
openaire   +1 more source

Interstitial Lung Disease in ANCA‐Associated Vasculitis: A European Multicentre Study

open access: yesArthritis &Rheumatology, Accepted Article.
Background Interstitial Lung Disease (ILD) can occur in association with ANCA‐associated Vasculitis (AAV‐ILD) or as an isolated entity with positive ANCA (ANCA‐ILD). However, data on the epidemiology and outcomes of these conditions remain limited.
Aglaia Chalkia   +18 more
wiley   +1 more source

POS-346 DEVELOPMENT AND TESTING OF THE EARLY-STAGE CHRONIC KIDNEY DISEASE SELF-MANAGEMENT (esCKD-SM) QUESTIONNAIRE

open access: yesKidney International Reports, 2021
M. SMEKAL   +9 more
doaj   +1 more source

Metabolism Score for Visceral Fat (METS-VF): A New Predictive Surrogate for CKD Risk

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2022
Ling Feng,1,2,* Tong Chen,3,* Xuan Wang,1 Chongxiang Xiong,1,4 Jianhui Chen,1 Shiquan Wu,3 Jing Ning,3 Hequn Zou1,3 1Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, People’s Republic of China ...
Feng L   +7 more
doaj  

Performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Calculator in Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, Accepted Article.
Objective Evaluate performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) calculator in rheumatoid arthritis (RA). Methods Patients with RA were matched up to 10 controls on age, sex, and enrollment year using national Veterans Health Administration (VHA), Medicare, and National Death Index data (2006‐2020).
Tate M. Johnson   +13 more
wiley   +1 more source

Effects of Renal and Hepatic Impairment on the Pharmacokinetics of Zilurgisertib

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Small‐molecule activin receptor‐like kinase‐2 inhibitor zilurgisertib (INCB000928) is under investigation in a pivotal trial for the treatment of fibrodysplasia ossificans progressiva (FOP), an ultrarare genetic condition. This analysis assessed effects of renal and hepatic impairment on zilurgisertib pharmacokinetics.
Yan‐ou Yang   +5 more
wiley   +1 more source

Adenine overload induces ferroptosis in human primary proximal tubular epithelial cells

open access: yesCell Death and Disease, 2022
Muhammad Ali Khan   +9 more
doaj   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

THE IMPROVEMENT OF GYPSUM SAND SOILS IN UNSATURATED CONDITIONS USING A MODIFIED OEDOMETER DEVICE

open access: yesMağallaẗ Al-kūfaẗ Al-handasiyyaẗ
This work offers recommendations on the best percentages of CKD (Cement Kiln Dust) to use for soil stabilization to reduce compressibility problems 1%, 2%, 3%, 4%, and 5% for projects where gypsum sand soil is common.
Mustafa M. Abdalhusein   +3 more
doaj   +1 more source

Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Tranexamic acid (TXA) stabilizes clot formation by inhibiting fibrin degradation and improves postoperative outcomes. However, rare adverse events (e.g., thrombosis, seizures) warrant dose–risk evaluation. This study examines how perioperative blood loss and transfusion practices affect TXA concentrations during paediatric scoliosis surgery ...
Paula Alexandra Sá   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy